25 July 2014
|
AIM: RENE |
ReNeuron Group plc
("ReNeuron" or the "Company")
Director/PDMR Shareholding
The Board of ReNeuron Group plc (AIM: RENE.L) has been informed that Michael Hunt, Chief Executive Officer and John Sinden, Chief Scientific Officer of the Company have today each purchased 93,892 ordinary shares of 1 pence ("Ordinary Shares") at a price of 3.5 pence per share.
Following this transaction, Mr Hunt is interested in a total of 1,346,915 Ordinary Shares in the Company, representing approximately 0.08% of the total issued share capital. Mr Sinden is interested in a total of 2,305,794 Ordinary Shares in the Company, representing approximately 0.13% of the total issued share capital.
Enquiries:
ReNeuron |
+44 (0) 1483 302560 |
Michael Hunt, Chief Executive Officer |
|
Dr John Sinden, Chief Scientific Officer |
|
|
|
Buchanan |
+44 (0) 20 7466 5000 |
Mark Court, Fiona Henson, Sophie Cowles |
|
|
|
Cenkos Securities |
+44 (0) 20 7397 8900 |
Stephen Keys, Dr Christopher Golden (NOMAD and Broker) |
|
Andy Roberts (Sales) |
|